SPS
CABA icon

Susquehanna Portfolio Strategies’s Cabaletta Bio CABA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.3K Buy
+17,595
New +$48.9K ﹤0.01% 952
2025
Q4 		– Sell
-33,937
Closed -$79.4K – 1016
2025
Q3 		$79.4K Buy
+33,937
New +$58.2K ﹤0.01% 1013

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna Portfolio Strategies's CABA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Cabaletta Bio (CABA) in Q1 2026: 17,595 shares worth $47.3K. The stake represents ﹤0.01% of the portfolio and ranks #952 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in CABA as recently as Q3 2025.

Susquehanna Portfolio Strategies first reported a position in CABA in Q3 2025 and has held it in 2 quarters since. The position peaked at $79.4K in Q3 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Susquehanna Portfolio Strategies held 17,595 shares of Cabaletta Bio worth $47.3K as of Q1 2026.
  • Cabaletta Bio was a new Susquehanna Portfolio Strategies position in Q1 2026.
  • Cabaletta Bio made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #952 holding.
  • Susquehanna Portfolio Strategies first reported a position in Cabaletta Bio in Q3 2025 and has held it in 2 quarters since.
  • Susquehanna Portfolio Strategies's Cabaletta Bio position peaked at $79.4K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.